Skip to content
Home
Our Science
Pipeline & Assets
Team & Investors
Careers
News & Resources
Connect
News
& Resources
Featured Stories
GlobeNewswire
Siren Biotechnology Awarded $8M in Non-Dilutive Grant Funding from CIRM to Support Clinical Development of SRN-101 in High-Grade Glioma
Read More
Siren Biotechnology Announces FDA Clearance of First IND, Advancing Company to Clinical Stage
Read More
GlobeNewswire
Siren Biotechnology Publishes Foundational AAV Immuno-Gene Therapy Data and Announces Presentations at ASGCT 2026
Read More
News
Patient Resources
Videos
Publications & Presentations
All
Media Coverage
Press Releases
Media Coverage
|
Posted on 10.11.24
Siren CEO & Founder Dr. Nicole Paulk honored as one of the Most Influential Women in Bay Area Business
Read More
Media Coverage
|
Posted on 9.17.24
AAV downstream challenges: expert insights
Read More
Media Coverage
|
Posted on 8.15.24
Siren Biotechnology Wins Beckman Coulter SPRI Grants for Genomic Research
Read More
Media Coverage
|
Posted on 8.9.24
Unveiling the critical pathways in AAV potency evaluation and future trends in gene therapy
Read More
Media Coverage
|
Posted on 7.26.24
BioBreakthroughs: Gene Therapy Innovation
Read More
Media Coverage
|
Posted on 6.28.24
Building A Universal AAV For Cancer
Read More
Media Coverage
|
Posted on 6.4.24
MilliporeSigma Announces Siren Biotechnology as Winner of its North American Advance Biotech Grant
Read More
Press Releases
|
Posted on 5.8.24
Siren Biotechnology and Catalent Enter Partnership for Manufacturing of AAV Gene Therapies for Cancer
Read More
Media Coverage
|
Posted on 4.27.24
How Viral Gene Therapy will Revolutionize Cancer Treatment
Read More
Media Coverage
|
Posted on 4.3.24
Biopharma’s AI Revolution | The Future of Medicine
Read More
1
2
3
4
5
6
